- Home
- CPHI vs CYCN Comparison
CPHI vs CYCN Comparison
Compare CPHI & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- CYCN
- Stock Information
- Founded
- CPHI N/A
- CYCN 2018
- Country
- CPHI China
- CYCN United States
- Employees
- CPHI N/A
- CYCN N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- CYCN Health Care
- Exchange
- CPHI Nasdaq
- CYCN Nasdaq
- Market Cap
- CPHI 7.3M
- CYCN 6.5M
- IPO Year
- CPHI N/A
- CYCN N/A
- Fundamental
- Price
- CPHI $1.83
- CYCN $2.81
- Analyst Decision
- CPHI
- CYCN
- Analyst Count
- CPHI 0
- CYCN 0
- Target Price
- CPHI N/A
- CYCN N/A
- AVG Volume (30 Days)
- CPHI 152.1K
- CYCN 21.8K
- Earning Date
- CPHI 08-13-2025
- CYCN 08-06-2025
- Dividend Yield
- CPHI N/A
- CYCN N/A
- EPS Growth
- CPHI N/A
- CYCN N/A
- EPS
- CPHI N/A
- CYCN N/A
- Revenue
- CPHI $4,295,377.00
- CYCN $2,081,000.00
- Revenue This Year
- CPHI N/A
- CYCN N/A
- Revenue Next Year
- CPHI N/A
- CYCN N/A
- P/E Ratio
- CPHI N/A
- CYCN N/A
- Revenue Growth
- CPHI N/A
- CYCN N/A
- 52 Week Low
- CPHI $1.20
- CYCN $1.27
- 52 Week High
- CPHI $3.35
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- CPHI 52.11
- CYCN 41.24
- Support Level
- CPHI $1.55
- CYCN $3.02
- Resistance Level
- CPHI $1.91
- CYCN $3.16
- Average True Range (ATR)
- CPHI 0.18
- CYCN 0.21
- MACD
- CPHI 0.02
- CYCN -0.03
- Stochastic Oscillator
- CPHI 61.38
- CYCN 16.26
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.